# Nuclide record y-mabs (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/y-mabs/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "y-mabs" ;
  schema:name "Y-mAbs Therapeutics"@en ;
  schema:description "MSK spin-out that commercialises naxitamab, the humanised anti-GD2 antibody for relapsed neuroblastoma, and develops pretargeted radioimmunotherapy."@en ;
  schema:url <https://nuclide.cc/companies/y-mabs/>, <https://www.ymabs.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.ymabs.com> ;
  schema:addressCountry "US" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/i-131/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroblastoma/> .